Summary
An investigational potassium binder, RLY5016, prevented hyperkalemia in patients with heart failure, according to findings from the phase II PEARL-HF study [NCT00868439].
- Cardiology Clinical Trials
- Heart Failure
- © 2010 MD Conference Express